X

Health-Related Mechanisms Behind Exercise

By: Sairah Sheikh, PharmD Candidate c/o 2024 Increased physical activity is often touted as a lifestyle choice that improves bodily…

eMAR

The Current Landscape of Treatment Options for Alzheimer’s Disease

By: Anureet Kaur, PharmD Candidate c/o 2024  Alzheimer’s disease (AD) is an epidemic. Currently, the neurodegenerative disorder holds the title…

eMAR

6th Year Perspective: Guide for Application-Based APPEs

By: Sarah Adly, PharmD Candidate c/o 2024 Applying to advanced professional pharmacy experience (APPE) rotations can be a daunting experience.…

eMAR

It’s in Our Blood: An Exploration of Gene Therapies for Hemophilia A and B

By: Holly Nguyen, PharmD Candidate ℅ 2024 Hemophilia is a severe hereditary hemorrhagic disorder derived from gene mutations that make…

eMAR

Efficacy of Cabozantinib, Nivolumab, and Ipilimumab Combination Therapy in Advanced Clear-Cell Renal-Cell Carcinoma

By: Shakhzoda Rakhimova, PharmD Candidate ℅ 2024 Introduction Renal-cell carcinoma (RCC) is a type of kidney cancer in which malignant…

eMAR

FDA Falls Behind on Sunscreen Approvals

By: Ashley Dao, PharmD Candidate c/o 2024 Melanoma is the fifth most common cause of cancer in the United States…

eMAR

Rho Chi Talks: The Path to Pharmaceutical Industry

Featuring: Fawad Piracha, PharmD, MBA, IgCP By: Holly Nguyen, PharmD Candidate ℅ 2024 Fawad Piracha is a ‘16 alumnus of…

eMAR

Zuranolone: An Oral Development in the Treatment of Postpartum Depression

By: Giavanna Carr, PharmD Candidate c/o 2025 Postpartum depression, also known as PPD, is classified as perinatal depression, which is…

eMAR

FDA Grants Approval for AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine

By: Urooj K. Malik, PharmD Candidate c/o 2024 On May 3, 2023, the United States (U.S.) Food and Drug Administration…

eMAR

6th Year Perspective: Conducting Research Projects and Attending Midyear

Featuring: Urooj K. Malik, PharmD Candidate c/o 2024 By: Isabelle Lim, PharmD Candidate c/o 2024 Urooj is a sixth-year pharmacy…

eMAR